» Authors » Stefania Ruiu

Stefania Ruiu

Explore the profile of Stefania Ruiu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 248
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Orru A, Marchese G, Ruiu S
Pharmacology . 2023 Feb; 108(3):301-307. PMID: 36754044
The anti-inflammatory properties of the medicinal plant Withania somnifera (L.) Dunal (WS) are generally related to withanolides; consistently, several strategies are under investigation to increase the concentration of these compounds...
2.
Murineddu G, Asproni B, Corona P, Piras S, Lazzari P, Ruiu S, et al.
Molecules . 2019 May; 24(9). PMID: 31035548
In this work, the synthesis of the cannabinoid receptor 1 neutral antagonists 8-chloro-1-(2,4-dichlorophenyl)--piperidin-1-yl-4,5-dihydrobenzo-1-6-oxa-cyclohepta[1,2-]pyrazole-3-carboxamide and its deaza cyclohexyl analogue has led to a deepening of the structure-activity studies of this class...
3.
Caputi F, Acquas E, Kasture S, Ruiu S, Candeletti S, Romualdi P
BMC Complement Altern Med . 2018 Jan; 18(1):9. PMID: 29316911
Background: Behavioral studies demonstrated that the administration of Withania somnifera Dunal roots extract (WSE), prolongs morphine-elicited analgesia and reduces the development of tolerance to the morphine's analgesic effect; however, little...
4.
Rosas M, Porru S, Fenu S, Ruiu S, Peana A, Papale A, et al.
Psychopharmacology (Berl) . 2016 Jun; 233(15-16):2943-54. PMID: 27245230
Rationale: Despite the critical role attributed to phosphorylated extracellular signal regulated kinase (pERK1/2) in the nucleus accumbens (Acb) in the actions of addictive drugs, the effects of morphine on ERK1/2...
5.
Orru A, Casu M, Tambaro S, Marchese G, Casu G, Ruiu S
Behav Pharmacol . 2015 Sep; 27(1):57-68. PMID: 26397759
Withania somnifera (L.) Dunal extracts (WSEs) may possess therapeutic perspectives in the treatment of inflammation and pain. We aimed to evaluate the antinociceptive property of a WSE in the formalin...
6.
Loriga G, Lazzari P, Manca I, Ruiu S, Falzoi M, Murineddu G, et al.
Bioorg Med Chem . 2015 Aug; 23(17):5527-38. PMID: 26252963
Here we report the investigation of diazabicycloalkane cores as potential new scaffolds for the development of novel analogues of the previously reported diazatricyclodecane selective delta (δ) opioid agonists, as conformationally...
7.
Ruiu S, Anzani N, Orru A, Floris C, Caboni P, Alcaro S, et al.
J Nat Prod . 2015 Jan; 78(1):69-76. PMID: 25562563
Fractionation of the bioactive dichloromethane extract from the aerial parts of Stachys glutinosa led to the isolation of four flavones, xanthomicrol (1), sideritoflavone (2), 8-methoxycirsilineol (3), and eupatilin (4), along...
8.
Pinna G, Curzu M, Dore A, Lazzari P, Ruiu S, Pau A, et al.
Eur J Med Chem . 2014 Aug; 85:747-57. PMID: 25134064
A series of dihydrothienocyclopentapyrazole-based derivatives was synthesized and evaluated for the affinity at CB1 and CB2 receptors. The major term, the 6-methyl-1-(1,4-dichlorophenyl)-N-piperidinyl)-1,4-dihydrothieno[2',3'-4,5]cyclopenta[1,2-c]pyrazole-3-carboxamide (6a), displayed a high affinity and good selectivity...
9.
Pinna G, Loriga G, Lazzari P, Ruiu S, Falzoi M, Frau S, et al.
Eur J Med Chem . 2014 Jun; 82:281-92. PMID: 24922543
A new series of 1H-benzofuro[3,2-c]pyrazole-3-carboxamides was synthesized. The novel compounds (15-24) were evaluated for their affinity to CB2 and CB1 cannabinoid receptors. The synthesis of the title compounds takes advantage...
10.
Piras S, Casu G, Casu M, Orru A, Ruiu S, Pilleri A, et al.
Ther Clin Risk Manag . 2014 Apr; 10:241-53. PMID: 24729711
In the last few decades, substantial research has focused on the possibility of early detection and prevention of the first psychotic episode in young individuals at risk of developing this...